What institutional recommendations guide the choice between brachytherapy and MR-linac-guided SBRT for locally advanced prostate cancer, given that no large trials have directly compared the two?

There is randomized data demonstrating the superiority of brachytherapy boost over EBRT alone mainly from the well-discussed ASCENDE-RT trial. To my knowledge, there is no such data for SBRT (whether alone or as a boost) in this patient population. So, I do not see how they can be considered equal o...

ASCENDE-SBRT is currently accruing and will be essential to answering this question.

If a patient is a candidate for both approaches from technical and medical standpoints, I review the potential upsides and drawbacks of each approach and have as much of a shared decision with the patient as possibl...